Andrew Kidd

Andrew Kidd

Chief Executive Officer en Tentarix Biotherapeutics LP .

Fortuna: 9 700 $ al 31/12/2023

48 años
Health Technology
Consumer Services

Perfil

Andrew Kidd is currently the Chief Executive Officer at Tentarix Biotherapeutics LP.
Previously, he served as the CEO, Chief Financial & Accounting Officer at Aptinyx, Inc. from 2017 to 2023.
Prior to that, he held positions at Baxter International, Inc. as Vice President-Strategy & Business Development, and at Baxter Corp.
as General Manager.
Dr. Kidd completed his undergraduate studies at the University of Oxford and the University of Cambridge.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
24/04/2023 101 043 ( 0.15% ) 9 700 $ 31/12/2023

Cargos activos de Andrew Kidd

EmpresasCargoInicio
Chief Executive Officer 23/04/2024
Todos los cargos activos de Andrew Kidd

Antiguos cargos conocidos de Andrew Kidd.

EmpresasCargoFin
APTINYX Chief Executive Officer 30/06/2023
Corporate Officer/Principal -
BAXTER INTERNATIONAL INC. Corporate Officer/Principal -
Ver el detalle de la experiencia de Andrew Kidd.

Formación de Andrew Kidd.

University of Oxford Undergraduate Degree
University of Cambridge Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andrew Kidd.

Relaciones

30

Relaciones de 1er grado

6

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas2
BAXTER INTERNATIONAL INC.

Health Technology

APTINYX

Health Technology

Empresas privadas2

Health Technology

Health Technology

Ver las conexiones de la empresa